To treat the neuroblastoma, Luke underwent ten cycles of chemotherapy, immunotherapy, and radiotherapy, and by Christmas 2017, his body was free of cancer. Unfortunately, the probability of relapse in this type of cancer was high, and Luke relapsed in April 2018.
After Luke's cancer had spread throughout his body, his family searched for clinical trials and enrolled him as the first patient on an international MiNivAN trial in Southampton. Despite the diagnosis being terminal, Luke remained positive and responsive throughout the treatment.
As his family tried to come to terms with the devastating news, they faced the daunting task of making the most of the precious time they had left with him. Luke passed away on December 23, 2018, which left his family heartbroken but determined to honour his memory.
They used their grief and pain to establish a neuroblastoma awareness charity in his name. The goal of the charity was to raise awareness and funds for research to prevent other families from suffering the same tragedy.